I IRHYTHM TECHNOLOGIES INC
| Market Cap | $3.93B |
| P/E Ratio | — |
| Forward P/E | 145.35 |
| Dividend Yield | — |
| Beta | 1.15 |
| 52W Range | $92.52 - $212.00 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 53 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Smith MervinEVP Strategic Business Ops | Sale | 2,585 | $114.30 | $295.47K | 16 Mar 2026 | 16 Mar 2026 |
| Shrishrimal SumiEVP, Chief Risk Officer | Sale | 978 | $128.44 | $125.62K | 02 Mar 2026 | 03 Mar 2026 |
| Shrishrimal SumiEVP, Chief Risk Officer | Sale | 906 | $128.44 | $116.37K | 02 Mar 2026 | 03 Mar 2026 |
| Shrishrimal SumiEVP, Chief Risk Officer | Sale | 946 | $128.44 | $121.50K | 02 Mar 2026 | 03 Mar 2026 |
| Blackford Quentin S.President and CEO | Sale | 4,347 | $128.44 | $558.33K | 02 Mar 2026 | 03 Mar 2026 |
| Wilson Daniel G.Chief Financial Officer | Sale | 815 | $128.44 | $104.68K | 02 Mar 2026 | 03 Mar 2026 |
| Smith MervinEVP Strategic Business Ops | Sale | 752 | $128.44 | $96.59K | 02 Mar 2026 | 03 Mar 2026 |
| Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Sale | 1,230 | $128.45 | $158.00K | 02 Mar 2026 | 03 Mar 2026 |
| Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Sale | 1,487 | $128.45 | $191.00K | 02 Mar 2026 | 03 Mar 2026 |
| Rosenbaum Marc WadeChief Accounting Officer | Sale | 399 | $128.45 | $51.25K | 02 Mar 2026 | 03 Mar 2026 |
| Blackford Quentin S.President and CEO | Sale | 5,423 | $128.44 | $696.55K | 02 Mar 2026 | 03 Mar 2026 |
| Blackford Quentin S.President and CEO | Sale | 4,043 | $128.44 | $519.29K | 02 Mar 2026 | 03 Mar 2026 |
| Wilson Daniel G.Chief Financial Officer | Sale | 1,261 | $128.45 | $161.98K | 02 Mar 2026 | 03 Mar 2026 |
| Wilson Daniel G.Chief Financial Officer | Sale | 564 | $128.45 | $72.45K | 02 Mar 2026 | 03 Mar 2026 |
| Wilson Daniel G.Chief Financial Officer | Sale | 755 | $128.44 | $96.97K | 02 Mar 2026 | 03 Mar 2026 |
| Smith MervinEVP Strategic Business Ops | Sale | 600 | $128.44 | $77.07K | 02 Mar 2026 | 03 Mar 2026 |
| Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Sale | 1,310 | $128.45 | $168.26K | 02 Mar 2026 | 03 Mar 2026 |
| Rosenbaum Marc WadeChief Accounting Officer | Sale | 417 | $128.45 | $53.56K | 02 Mar 2026 | 03 Mar 2026 |
| Patterson ChadCHIEF COMM & PRODUCT OFFICER | Sale | 3,030 | $128.44 | $389.19K | 02 Mar 2026 | 03 Mar 2026 |
| Patterson ChadCHIEF COMM & PRODUCT OFFICER | Sale | 1,414 | $128.44 | $181.62K | 02 Mar 2026 | 03 Mar 2026 |
| Murphy Patrick MichaelCBO and CLO | Sale | 1,139 | $128.45 | $146.30K | 02 Mar 2026 | 03 Mar 2026 |
| Murphy Patrick MichaelCBO and CLO | Sale | 1,190 | $128.44 | $152.85K | 02 Mar 2026 | 03 Mar 2026 |
| Murphy Patrick MichaelCBO and CLO | Sale | 2,028 | $128.44 | $260.47K | 02 Mar 2026 | 03 Mar 2026 |
| Rosenbaum Marc WadeChief Accounting Officer | Sale | 4,797 | $135.42 | $649.60K | 25 Feb 2026 | 26 Feb 2026 |
| Smith MervinEVP Strategic Business Ops | Sale | 4,041 | $135.42 | $547.23K | 25 Feb 2026 | 26 Feb 2026 |
| Patterson ChadCHIEF COMM & PRODUCT OFFICER | Sale | 8,967 | $135.42 | $1.21M | 25 Feb 2026 | 26 Feb 2026 |
| Murphy Patrick MichaelCBO and CLO | Sale | 7,805 | $135.42 | $1.06M | 25 Feb 2026 | 26 Feb 2026 |
| Blackford Quentin S.President and CEO | Sale | 25,540 | $135.42 | $3.46M | 25 Feb 2026 | 26 Feb 2026 |
| Shrishrimal SumiEVP, Chief Risk Officer | Sale | 6,217 | $135.42 | $841.90K | 25 Feb 2026 | 26 Feb 2026 |
| Wilson Daniel G.Chief Financial Officer | Sale | 5,188 | $135.42 | $702.55K | 25 Feb 2026 | 26 Feb 2026 |
| Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Sale | 7,804 | $135.42 | $1.06M | 25 Feb 2026 | 26 Feb 2026 |
| Mervin SmithEVP Strategic Business Ops | Sale | 732 | $140.91 | $103.15K | 24 Feb 2026 | 25 Feb 2026 |
| Marc Wade RosenbaumChief Accounting Officer | Sale | 280 | $140.91 | $39.45K | 24 Feb 2026 | 25 Feb 2026 |
| Rosenbaum Marc WadeChief Accounting Officer | Sale | 280 | $140.91 | $39.45K | 24 Feb 2026 | 25 Feb 2026 |
| Smith MervinEVP Strategic Business Ops | Sale | 732 | $140.91 | $103.15K | 24 Feb 2026 | 25 Feb 2026 |
| TALWALKAR ABHIJIT Y | Sale | 1,637 | $147.62 | $241.65K | 23 Feb 2026 | 24 Feb 2026 |
| TALWALKAR ABHIJIT Y | Sale | 572 | $146.95 | $84.06K | 23 Feb 2026 | 24 Feb 2026 |
| TALWALKAR ABHIJIT Y | Sale | 1,725 | $145.32 | $250.67K | 23 Feb 2026 | 24 Feb 2026 |
| TALWALKAR ABHIJIT Y | Sale | 1,378 | $143.40 | $197.61K | 23 Feb 2026 | 24 Feb 2026 |
| Patterson ChadCHIEF COMM & PRODUCT OFFICER | Sale | 280 | $184.83 | $51.75K | 02 Dec 2025 | 03 Dec 2025 |
| Murphy Patrick MichaelCBO and CLO | Sale | 2,478 | $184.83 | $458.01K | 02 Dec 2025 | 03 Dec 2025 |
| Patrick Michael MurphyCBO and CLO | Sale | 2,478 | $184.83 | $458.01K | 02 Dec 2025 | 03 Dec 2025 |
| Chad PattersonCHIEF COMM & PRODUCT OFFICER | Sale | 280 | $184.83 | $51.75K | 02 Dec 2025 | 03 Dec 2025 |
| TALWALKAR ABHIJIT Y | Sale | 89 | $177.85 | $15.83K | 10 Nov 2025 | 12 Nov 2025 |
| TALWALKAR ABHIJIT Y | Sale | 637 | $175.96 | $112.08K | 10 Nov 2025 | 12 Nov 2025 |
| TALWALKAR ABHIJIT Y | Sale | 1,585 | $174.38 | $276.40K | 10 Nov 2025 | 12 Nov 2025 |
| TALWALKAR ABHIJIT Y | Sale | 1,479 | $172.32 | $254.86K | 10 Nov 2025 | 12 Nov 2025 |
| TALWALKAR ABHIJIT Y | Sale | 1,300 | $174.94 | $227.43K | 10 Nov 2025 | 12 Nov 2025 |
| TALWALKAR ABHIJIT Y | Sale | 222 | $172.83 | $38.37K | 10 Nov 2025 | 12 Nov 2025 |
| Blackford Quentin S.President and CEO | Sale | 14,059 | $182.94 | $2.57M | 03 Nov 2025 | 04 Nov 2025 |
| Quentin S. BlackfordPresident and CEO | Sale | 14,059 | $182.94 | $2.57M | 03 Nov 2025 | 04 Nov 2025 |
| Wilson Daniel G.Chief Financial Officer | Sale | 8,000 | $207.44 | $1.66M | 31 Oct 2025 | 03 Nov 2025 |
| Daniel G. WilsonChief Financial Officer | Sale | 8,000 | $207.44 | $1.66M | 31 Oct 2025 | 03 Nov 2025 |
Frequently Asked Questions
What is IRTC stock price today?
IRHYTHM TECHNOLOGIES INC (IRTC) is currently trading at $121.56. The stock has a 52-week range of $92.52 to $212.00 and a market capitalization of $3.93B.
Is IRTC a good stock to buy in 2026?
IRHYTHM TECHNOLOGIES INC has a P/E ratio of N/A (forward P/E: 145.3), a dividend yield of none, and 1-year performance of +23.4%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling IRTC stock?
There have been 53 insider transactions for IRTC in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has IRTC stock performed over the past year?
IRHYTHM TECHNOLOGIES INC (IRTC) has returned +23.4% over the past 12 months. The stock traded between $92.52 and $212.00 during this period, and is currently at $121.56.
Which hedge funds own IRTC (IRHYTHM TECHNOLOGIES INC)?
0 tracked hedge funds currently hold IRTC in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is IRTC's market cap and valuation?
IRHYTHM TECHNOLOGIES INC (IRTC) has a market capitalization of $3.93B. The trailing P/E ratio is N/A and forward P/E is 145.3. The stock is classified in the Healthcare sector.
What is IRTC's revenue and profitability?
IRHYTHM TECHNOLOGIES INC reported revenue of $747.14M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.15.
What sector is IRTC in and who are its biggest institutional holders?
IRHYTHM TECHNOLOGIES INC (IRTC) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.